CD24 Antibody (SN3) - BSA Free NB100-64861 from Novus Biologicals, a Bio-Techne Brand

Product Specs
ItemCD24 Antibody (SN3) - BSA Free
CompanyNovus Biologicals, a Bio-Techne Brand
Price $449.00Supplier Page View Company Product Page
Catalog NumberNB100-64861
ImmunogenGlycoproteins purified from human NALM-1 cell line
NCBI Gene AliasesCD24A
Concentration1.0 mg/ml
ApplicationsFlow Cytometry,Immunohistochemistry,Immunohistochemistry-Frozen
FormatPBS
ClonalityMonoclonal
TargetCD24
Conjugate/TagUnconjugated
Quantity0.1 mg (also 0.025 mg)
ReactivityHuman
IsotypeIgG1
CloneSN3
HostMouse
NCBI Full Gene NameCD24 molecule
PurityProtein A purified
Research AreaCancer, Neuronal Cell Markers, Stem Cell Markers
Antibody TypePrimary Antibodies
StorageStore at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles

Specifications/Features

Available conjugates: Available conjugates: Unconjugated

Specificity: Recognizes the human CD24 cell surface antigen, a heavily glycosylated molecule of 35-45kD. CD24 is expressed by granulocytes and B lymphocytes, and by some activated T cells and T cell malignancies.

Sizes Available: 0.1 mg (also 0.025 mg)

Add to Compare List

Novus Biologicals, a Bio-Techne Brand

United States: 10771 E Easter Ave

Centennial, Colorado 80112

United States

Phone:
303-730-1950
888-506-6887

Email: novus@novusbio.com

Company Profile

Website: https://www.novusbio.com

(1) ABHD17C‐Mediated S‐Depalmitoylation of BCL6B Enhances CD24 Transcription to Resist Macrophage Phagocytosis in Pancreatic CancerAdvanced ScienceMay 19, 2026Yalu Zhang, Di Cui, Fanzheng Meng, Xu Zhu, Liang Zhu, Liang Wu, Haifeng Hu, Jizhou Wang, Hanhui Yao, Lianxin LiuPC cells were prepared in serum‐free medium, supplemented with anti‐CD24 mAb (10 µg/mL; Clone SN3; NB100‐64861, Novus Biologicals), anti‐Siglec‐10 mAb (10 µg/mL; Clone 5G6; NBP3‐21494, Novus Biologicals), or an

(2) Prognostic effect of programmed cell death ligand 1/programmed cell death 1 expression in cancer stem cells of human oral squamous cell carcinomaOncology lettersJanuary 1, 0001"Todoroki K, Abe Y, Matsuo K, Nomura H, Kawahara A, Nakamura Y, Nakamura M, Seki N, Kusukawa J."variant 3, Bender MedSystems, Vienna, Austria), CD24 (mouse anti-human monoclonal antibody, cat. No. NB100-64861, 1:100 dilution, clone SN3, Novus Biologics, Briarwood, USA), PD-L1 (rabbit anti-human monoclonal antibody,

(3) "Plexin-B3 expression stimulates MET signaling, breast cancer stem cell specification, and lung metastasis"Cell reportsJanuary 1, 0001"Zuo Q, Yang Y, Lyu Y, Yang C, Chen C, Salman S, Huang TY, Wicks EE, Jackson W 3rd, Datan E, et al."

(4) CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapyNatureJanuary 1, 0001"Barkal AA, Brewer RE, Markovic M, Kowarsky M, Barkal SA, Zaro BW, Krishnan V, Hatakeyama J, Dorigo O, Barkal LJ, et al."

(5) An in-situ peptide-antibody self-assembly to block CD47 and CD24 signaling enhances macrophage-mediated phagocytosis and anti-tumor immune responsesNature communicationsJanuary 1, 0001"Zhang W, Zeng Y, Xiao Q, Wu Y, Liu J, Wang H, Luo Y, Zhan J, Liao N, Cai Y."

(6) Phagocytosis-initiated tumor hybrid cells acquire a c-Myc-mediated quasi-polarization state for immunoevasion and distant disseminationNature communicationsJanuary 1, 0001"Chou CW, Hung CN, Chiu CH, Tan X, Chen M, Chen CC, Saeed M, Hsu CW, Liss MA, Wang CM, et al."

(7) Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle-cell lymphoma and chronic lymphocytic leukaemiaJournal of cellular and molecular medicineJanuary 1, 0001"Aroldi A, Mauri M, Ramazzotti D, Villa M, Malighetti F, Crippa V, Cocito F, Borella C, Bossi E, Steidl C, et al."

(8) "CD24 and CK4 are upregulated by SIM2, and are predictive biomarkers for chemoradiotherapy and surgery in esophageal cancer"International journal of oncologyJanuary 1, 0001"Takashima K, Fujii S, Komatsuzaki R, Komatsu M, Takahashi M, Kojima T, Daiko H, Minashi K, Chiwaki F, Muto M, et al."S2367; Dako; Agilent Technologies, Inc.; pH 9.0) for 10 min (CK4 antigen). Anti‑CD24 (1:500; cat. no. NB100‑64861; Novus Biologicals, LLC) and anti‑CK4 antibodies (1:500; cat. no. ab9004; Abcam) were diluted at 1:500

(9) PARP1 controls the transcription of CD24 by ADP-ribosylating the RNA helicase DDX5 in pancreatic cancerThe international journal of biochemistry & cell biologyJanuary 1, 0001"Chen K, Dai M, Luo Q, Wang Y, Shen W, Liao Y, Zhou Y, Cheng W."

Be the First to Write a Review!

CD24 Antibody (SN3) - BSA Free

CD24 Antibody (SN3) - BSA Free from Novus Biologicals, a Bio-Techne Brand

Description

Specifications/Features

Novus Biologicals, a Bio-Techne Brand

Citations (9)

Reviews

CD24 Antibody (SN3) - BSA Free from Novus Biologicals, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map